<DOC>
	<DOCNO>NCT01653262</DOCNO>
	<brief_summary>Trial N01395 evaluate reduction nonpsychotic behavioral side effect subject Epilepsy switch BRV 200 mg/day discontinue LEV due side effect ; well efficacy , safety tolerability BRV . No statistical hypothesis test perform .</brief_summary>
	<brief_title>Effect Brivaracetam ( BRV ) Nonpsychotic Behavioral Side Effects Subjects Treated Previously With Levetiracetam ( LEV )</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subject wellcharacterized Epilepsy accord 1989 International League Against Epilepsy ( ILAE ) classification Subject Epilepsy investigator expect benefit Levetiracetam ( LEV ) investigator decide discontinue due nonpsychotic behavioral side effect follow introduction LEV Subject currently receive LEV recommend therapeutic dose ( dose range 1 g/day 3 g/day ) Subject currently treat minimum 2 maximum 3 AntiEpileptic Drugs ( AEDs ) include LEV . Vagal Nerve Stimulation ( VNS ) allow count concomitant AED Female subject without childbearing potential ( postmenopausal least 2 year , bilateral oophorectomy tubal ligation , complete hysterectomy ) eligible . Female subject childbearing potential eligible use medically accept contraceptive method Subject lifetime history suicide attempt ( include actual , interrupt aborted attempt ) , suicidal ideation past 6 month indicate positive response ( `` Yes '' ) either Question 4 Question 5 ColumbiaSuicide Severity Rating Scale ( CSSRS ) Visit 1 Subject whose seizure could reliably count regular basis due fast repetitive occurrence ( cluster flurry ) Subject history presence status epilepticus year precede Visit 1 Baseline Subject history presence know psychogenic nonepileptic seizure Subject clinical condition ( eg , bone marrow depression , chronic hepatic disease , and/or severe renal impairment ) impair reliable participation study necessitate use medication allow protocol Subject pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Brivaracetam</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Nonpsychotic behavior</keyword>
</DOC>